Common Contracts
9 similar Underwriting Agreement contracts by National Retail Properties, Inc., NNN Reit, Inc., Catabasis Pharmaceuticals Inc, others
ContractUnderwriting Agreement • May 29th, 2024 • NNN Reit, Inc. • Real estate investment trusts • New York
ContractUnderwriting Agreement • August 15th, 2023 • NNN Reit, Inc. • Real estate investment trusts • New York
As the Representatives, you have advised the Company (a) that you are authorized to enter into this underwriting agreement (this “Agreement”) on behalf of the several Underwriters, and (b) that the several Underwriters are willing, acting severally and not jointly, to purchase the principal amount of Notes set forth opposite their names in Schedule I hereto.
NATIONAL RETAIL PROPERTIES, INC. $450,000,000 3.000% Notes due 2052 UNDERWRITING AGREEMENTUnderwriting Agreement • September 24th, 2021 • National Retail Properties, Inc. • Real estate investment trusts • New York
National Retail Properties, Inc., a Maryland corporation (the “Company”), proposes to issue and sell to the several Underwriters named on Schedule I hereto (collectively, the “Underwriters”), for whom you are acting as Representatives (collectively, the “Representatives”), an aggregate principal amount of $450,000,000 3.000% Notes due 2052 (the “Notes”), to be issued under an indenture (as the same has been and may be amended and supplemented, the “Indenture”), dated as of March 25, 1998, as amended and supplemented by a Twentieth Supplemental Indenture (the “Twentieth Supplemental Indenture”), to be dated as of September 24, 2021, between the Company and U.S. Bank National Association, as successor trustee (the “Trustee”). The respective amounts of the Notes to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto.
NATIONAL RETAIL PROPERTIES, INC. $450,000,000 3.500% Notes due 2051 UNDERWRITING AGREEMENTUnderwriting Agreement • March 10th, 2021 • National Retail Properties, Inc. • Real estate investment trusts • New York
NATIONAL RETAIL PROPERTIES, INC. 7,000,000 Shares of Common Stock (Par Value $0.01 Per Share) UNDERWRITING AGREEMENTUnderwriting Agreement • September 9th, 2019 • National Retail Properties, Inc. • Real estate investment trusts • New York
National Retail Properties, Inc., a Maryland corporation (the “Company”), proposes to issue and sell to the several Underwriters named on Schedule I hereto (the “Underwriters”) for whom you are acting as Representatives (the “Representatives”) 7,000,000 shares (the “Firm Shares”) of its common stock, par value $0.01 per share (the “Common Stock”). The Company also proposes to grant to the Underwriters an option to purchase up to an additional 1,050,000 shares of Common Stock (the “Option Shares;” the Option Shares, together with the Firm Shares, hereinafter called the “Shares”). The respective amounts of the Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto.
SELLAS Life Sciences Group, Inc. 26,367,200 Shares Common Stock ($0.0001 par value per share) and Pre-Funded Warrants to Purchase up to 73,632,800 Shares of Common Stock and Warrants to Purchase up to 100,000,000 Shares of Common Stock Underwriting...Underwriting Agreement • June 18th, 2019 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
SELLAS Life Sciences Group, Inc., a corporation organized under the laws of Delaware (including any predecessor entities, the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representative”) are acting as Representative, (i) an aggregate of 26,367,200 shares of common stock, $0.0001 par value per share (“Common Stock”) of the Company (said shares to be issued and sold by the Company being hereinafter called the “Firm Shares”), (ii) pre-funded warrants to purchase up to an aggregate of 73,632,800 shares of Common Stock (the “Pre-Funded Warrants”) at an exercise price of $0.0001 per share and (iii) warrants of the Company to purchase up to an aggregate of 100,000,000 shares of Common Stock (the “Firm Common Warrants”) at an exercise price equal to $0.50 per share. The Firm Shares, Pre-Funded Warrants, and the Firm Common Warrants to be sold by the Company are collectively referred to as the “Firm Securities.” Th
Underwriting AgreementUnderwriting Agreement • October 22nd, 2018 • Pintec Technology Holdings LTD • Services-computer programming, data processing, etc. • New York
The Representatives have also advised the Company that the Underwriters will cause the Company to deposit on their behalf all of the Ordinary Shares to be purchased by them hereunder pursuant to the Deposit Agreement, dated as of [·], 2018 (the “Deposit Agreement”), to be entered into among the Company, The Bank of New York Mellon, as depositary (the “Depositary”) and all holders and beneficial owners from time to time of the ADSs. Upon deposit of any Ordinary Shares, the Depositary will issue the ADSs representing the Ordinary Shares so deposited. The ADSs may be evidenced by American Depositary Receipts (the “ADRs”). Each ADS will represent seven Ordinary Shares and each ADR may represent any number of ADSs. Unless the context otherwise requires, the terms “Underwritten Securities”, “Option Securities” and “Securities” shall be deemed to refer, respectively, to Underwritten Shares, Option Shares and Shares as well as, in each case, to any ADSs representing such securities and the ADR
UNDERWRITING AGREEMENTUnderwriting Agreement • December 7th, 2016 • SM Energy Co • Crude petroleum & natural gas • New York
Catabasis Pharmaceuticals, Inc. 2,500,000 Shares Common Stock ($0.001 par value per share) Underwriting AgreementUnderwriting Agreement • September 23rd, 2016 • Catabasis Pharmaceuticals Inc • Pharmaceutical preparations • New York
Catabasis Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware (the “Company”), proposes to sell to Cowen and Company, LLC (the “Underwriter”), 2,500,000 shares of common stock, $0.001 par value per share (“Common Stock”), of the Company (said shares to be issued and sold by the Company being hereinafter called the “Underwritten Securities”). The Company also proposes to grant to the Underwriter an option to purchase up to 375,000 additional shares of Common Stock (the “Option Securities”; the Option Securities, together with the Underwritten Securities, being hereinafter called the “Securities”). Certain terms used herein are defined in Section 20 hereof. Any reference herein to the Registration Statement, the Base Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 which were filed under the Exchange Act on or before the Effective Date of the Registration
